Immuno-oncology combinations： raising the tail of the survival curve
Immuno-oncology combinations： raising the tail of the survival curve
About this item
Full title
Author / Creator
Publisher
China: Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London SM2 5PT, UK
Journal title
Language
English
Formats
Publication information
Publisher
China: Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London SM2 5PT, UK
Subjects
More information
Scope and Contents
Contents
There have been exponential gains in immuno-oncology in recent times through the development of immune checkpoint inhibitors. Already approved by the U.S. Food and Drug Administration for advanced melanoma and non-small cell lung cancer, immune checkpoint inhibitors also appears to have significant antitumor activity in multiple other tumor types....
Alternative Titles
Full title
Immuno-oncology combinations： raising the tail of the survival curve
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c3cee8a608c8475dbf0a4d5c1495b33b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c3cee8a608c8475dbf0a4d5c1495b33b
Other Identifiers
ISSN
2095-3941
E-ISSN
2095-3941
DOI
10.20892/j.issn.2095-3941.2016.0015
